Tivantinib, CAS [[905854-02-6]]

Produktübersicht

• Artikelname: Tivantinib, CAS [[905854-02-6]]
• Artikelnummer: BYT-ORB1301058
• Hersteller Artikelnummer: orb1301058
• Alternativnummer: BYT-ORB1301058-5,BYT-ORB1301058-1,BYT-ORB1301058-10,BYT-ORB1301058-25,BYT-ORB1301058-50,BYT-ORB1301058-100,BYT-ORB1301058-200
• Hersteller: Biorbyt
• Kategorie: Biochemikalien
• Alternative Synonym: c-Met/HGFR, cMet, c-Met, cMet/HGFR, Apoptosis, ARQ 197, ARQ197, ARQ-197, HGFR, Inhibitor, inhibit, Tivantinib

Produktbeschreibung

Tivantinib (ARQ 197) is an orally administered small molecule that selectively inhibits the c-Met receptor tyrosine kinase. It has demonstrated antineoplastic activity in preclinical studies, showing efficacy in both in vitro cell proliferation assays and in vivo xenograft models of various cancers, including hepatocellular and non-small cell lung carcinomas.

Produkteigenschaften

• Molekulargewicht: 369.42
• Reinheit: 99.95% (May vary between batches)
• CAS Nummer: [905854-02-6]
• Formel: C23H19N3O2
• Target-Kategorie: c-Met/HGFR,Apoptosis

Anwendungsbeschreibung

• Anwendungsbeschreibung: Solubility: 10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.41 mM),DMSO:125 mg/mL (338.37 mM),H2O:< 1 mg/mL (insoluble or slightly soluble),Ethanol:< 1 mg/mL (insoluble or slightly soluble)